About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,818 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,818 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3781-3800 of 10,818 trials

Not yet recruitingPhase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).This study is testing a new investigational study drug called Urcosimod Ophthalmic Solution for the treatment of Neuropathic Corneal Pain (NCP).NCT07838506·Nashville, Tennessee TerminatedContinuation of Antiarrhythmics Following Ventricular Tachycardia Catheter AblationThe investigators aim to study if patients that undergo catheter ablation for ventricular tachycardia benefit from continuation of Vaughan-Williams class III antiarrhythmic drugs…NCT04208997·Nashville, Tennessee CompletedEvaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected AdultsThe purpose of this study is to evaluate the safety and immune response of an adenovirus-based HIV-1 vaccine regimen that includes two vaccines given at different time points in…NCT01095224·Birmingham, Alabama and 7 others CompletedAdaptResponse Clinical TrialThe purpose of this clinical study is to test the hypothesis that market released Cardiac Resynchronization Therapy (CRT) devices which contain the AdaptivCRT® (aCRT) algorithm…NCT02205359·Mesa, Arizona and 219 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedAMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaRATIONALE: Monoclonal antibodies, such as AMG-479, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00562380·Nashville, Tennessee

TerminatedAn Open Label Extension Study of STX209 in Subjects With Fragile X SyndromeStudy 22001, "A Double-Blind, Placebo-Controlled, Flexible-Dose Evaluation of the Efficacy, Safety, and Tolerability of STX209 in the Treatment of Irritability in Subjects with…NCT01013480·Los Angeles, California and 8 others

CompletedinformCLL™: A Disease Registry for Patients With Chronic Lymphocytic LeukemiaThe study is designed as a multicenter, prospective, observational registry of CLL/SLL patients who are initiating approved oral kinase inhibitors, BCL-2 inhibitors or other…NCT02582879·Huntsville, Alabama and 191 others

CompletedEvaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive AgentsThe purpose of this study is to evaluate the effect of canagliflozin (JNJ-28431754) on blood pressure reduction, compared to placebo, in patients with hypertension and type 2…NCT01939496·Birmingham, Alabama and 56 others

CompletedA Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid TumorsThe Phase 1b part of this study is conducted to assess the safety and tolerability of E7386 in combination with pembrolizumab in participants with previously treated selected…NCT05091346·Los Angeles, California and 31 others

CompletedA Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne VulgarisA Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne VulgarisNCT03170388·Hot Springs, Arkansas and 33 others

CompletedTesting Tissue Sodium Stores in CAPD Patients-Aims 1 & 2The investigators' overarching goal is to improve long-term outcomes for end stage renal disease (ESRD) patients.NCT02212327·Nashville, Tennessee

RecruitingStudy of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsThe investigational drug to be studied in this protocol, BCA101, is a first-in-class compound that targets both EGFR with TGFβ.NCT04429542·La Jolla, California and 19 others

TerminatedA 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's DiseaseThe name of this trial is MissionAD1.NCT02956486·Chandler, Arizona and 257 others

CompletedA 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast CancerThis is a neoadjuvant study to determine the feasibility and tolerability of 2 weeks of a very low carbohydrate ketogenic diet in combination with letrozole for patients with…NCT03962647·Nashville, Tennessee

CompletedTreatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary SiteThis is a non-randomized Phase II study.NCT00737243·Huntsville, Alabama and 20 others

RecruitingA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)Study ASTX030-01 is a multi-phase study comprising of Phases 1-3 Monotherapy arms, and Phase 1 and Phase 2 Combination Therapy arms.NCT04256317·Los Angeles, California and 70 others

CompletedEfficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary FibrosisORV-PF-01 is a two way, placebo controlled, cross-over study, to evaluate the effect of two doses of orvepitant on cough in patients with IPF.NCT05185089·Los Angeles, California and 36 others

CompletedA Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)The primary objective of this study is to evaluate the efficacy of ibrutinib in combination with obinutuzumab compared to chlorambucil in combination with obinutuzumab based on…NCT02264574·La Jolla, California and 70 others

CompletedA Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas AeruginosaThis is a phase 1b/2 study of a single dose of intravenous (IV) bacteriophage in males and non-pregnant females, at least 18 years old, diagnosed with Cystic Fibrosis (CF).NCT05453578·Tucson, Arizona and 18 others

CompletedINSPIRE Trial for Abdominal InfectionsThe INSPIRE Abdominal Infection Trial is a cluster-randomized controlled trial of HCA Healthcare hospitals comparing routine empiric antibiotic stewardship practices with…NCT05423743·Riverside, California and 100 others

PreviousPage 190 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville